Clinical TrialID 8186
Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
NCT06004752
Aplastic Anemia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8186
- Evidence Id
- 8186
- Core Evidence Id
- 8186
- Source Clinical Trial Id
- 8184
- Herb2 Clinical Trial Id
- HBCT008184
- Nct Id
- NCT06004752
- Title
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
- Status
- Recruiting
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Aplastic Anemia
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Ciclosporin|DRUG: Avatrombopag
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 30
- Outcome Measure
- ORR at 6 Months, Overall Response Rate (ORR) Defined as the Number of Participants Who Met the Criteria of Either Complete Response (CR) or Partial Response (PR), 6 months
- Sponsor Collaborator
- Peking Union Medical College Hospital
- Funded By
- OTHER
- Location
- Peking union medical college hospital, Beijing, China
- Other Id
- Avatrombopag-2
- Start Date
- 2023-08-17
- Primary Completion Date
- 2024-08
- Completion Date
- 2025-08
- First Posted
- 2023-08-22
- Results First Posted
- Last Update Posted
- 2023-12-08
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT06004752
- Title Cn
- Title En
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
- Bilingual Status
- semi_complete